Drying, Granulating, and Coating System Offers Modularity
The VENTILUS LE series for production-scale applications from Romaco offers three versions: LE-D for drying processes; LE-G for granulating fine solid particles; and the LE-C for coating them.
The VENTILUS LE series for production-scale applications from Romaco offers three versions: LE-D for drying processes; LE-G for granulating fine solid particles; and the LE-C for coating them. The three machines are designed for batch sizes from 40-1600 L. Larger batch volumes are possible on request. These Light Edition machines are available for those users that do not require all applications of the company’s Premium Edition, which integrates all VENTILUS process steps and features.
Users who simply require the VENTILUS in order to dry the fluidized bed can use the low-cost LE-D version. Integrated solutions for wet granulation with an upstream high-shear mixer as well as systems for wet and dry milling are available. All components are connected to the VENTILUS LE-D fluidized bed dryer via an enclosed material transfer system. Control, data recording, and cleaning of the processing line take place centrally.
The VENTILUS V 100 LE-C combines all three processing steps: drying, granulation, and coating. It contains the same core components as the Premium Edition with a central ROTOJET spray nozzle and an ORBITER booster. The rapid, homogeneous distribution of the spray liquid helps achieve shorter processing times and improved product quality.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
